Qiagen NV | QIA - Market Capitalization

Stock Price
42.02
Daily Change
0.63 1.52%
Monthly
-6.03%
Yearly
14.09%
Q1 Forecast
40.37

Qiagen NV reported $9.27B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 322M 180M Jun/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
argenx SE USD 39.38B 12.45B Feb/2026
Avita Medical AUD 140.79M 194.8M Jun/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Ionis Pharmaceuticals USD 11.8B 1.01B Feb/2026
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Organon & Co USD 1.89B 29.17M Feb/2026
Qiagen NV USD 9.46B 440.29M Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 18.11B 3.77B Feb/2026
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026